~~<i id='39135BE5B4'><strike id='39135BE5B4'><tt id='39135BE5B4'><pre id='39135BE5B4'></pre></tt></strike></i>~~

Home» explore» comprehensive

comprehensive

author：fashion 2025-09-29 12:27:17 Page View：2282

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： With clinical trial data readouts, here's how to spot spin
Next article： Drug repurposing or repositioning? The language matters

explore

Anesthesiologist group: stop taking Ozempic before surgery

EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

UnitedHealth’s Optum accused of antitrust violations in California

EmanateHealthsuedUnitedHealth'sOptum,allegingtheinsurerpushedittoagreenottocompeteforprimarycarephys

Walensky prepares to leave CDC — and Congress — behind

OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

UPS workers' union leader explains what's at stake as strike edges closer

3:43AUPSdeliveryvanisdrivenlongacitystreetinGardenGrove,Calif.,March29,2022.MikeBlake/Reuters,FILEWo